Future developments in antimicrobial agents

Professor David Livermore
Professor of Medical Microbiology, Norwich Medical School, University of East Anglia, UK

Professor David Livermore highlights increasing resistance and the major bacterial challenges we face. Beta-lactams, the most widely used antibiotic are losing their efficacy. However, there is hope for antimicorbial agents. Cefiderocol, murepavadin and gepotidacin/zoliflodacin all show promise in replacing spent antibiotics. Further, non-antibiotic approaches and improved molecular diagnostics, while not currently comprehensive, could revolutionise the field.

Últimos cursos

Ver más